SCHEMBL7704530

SCHEMBL7704530

CC(C)(C)Oc1cc(NC(=O)O)c(NC(=O)CC(=O)c2cccc(C#N)c2)cc1-c1ccccc1F

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 3/20 0.37
GSK3B P49841 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
RAB9A P51151 1/20 0.36
HDAC3 O15379 1/20 0.36
GRM5 P41594 1/20 0.36
CD274 Q9NZQ7 2/20 0.36
PDCD1 Q15116 1/20 0.36
ALDH1A1 P00352 1/20 0.35
GPR139 Q6DWJ6 1/20 0.35
POLB P06746 1/20 0.34
VNN1 O95497 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7145960 0.92 EGLN2 (0.36) DHODHGSK3BMEN1KMT2AHDAC3
SCHEMBL7703803 0.87 HTT (0.39) DHODHGSK3BMEN1KMT2ARAB9A
SCHEMBL7704536 0.86 DHODH (0.36) DHODHMEN1KMT2ARAB9ACD274
SCHEMBL7139979 0.85 ALDH1A1 (0.40) GSK3BMEN1KMT2ARAB9AHDAC3
SCHEMBL7140101 0.83 KCNQ4 (0.36) GSK3BMEN1KMT2AHDAC3ALDH1A1
SCHEMBL7142038 0.82 HTT (0.36) DHODHGSK3BMEN1KMT2AHDAC3
SCHEMBL7704377 0.82 ALDH1A1 (0.45) GSK3BMEN1KMT2ARAB9AGRM5
SCHEMBL7702829 0.81 GAA (0.37) DHODHMEN1KMT2ARAB9APOLB
SCHEMBL7704182 0.80 CYP3A4 (0.35) MEN1KMT2ARAB9AALDH1A1
SCHEMBL7703510 0.80 VCP (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed